Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

The new firm is raising a $150 million fund to back startups around science emerging outside Boston and San Francisco.

This Peninsula biotech company started as a way to find a cancer drug for a co-founder's father. It now layoffs show it’s ...

Industry insiders hope the Fed’s decision to cut rates for the first time in years will boost biotech investment. But the ...

We circle back to three small biotech stocks that recently were positively highlighted and moved up on good news. Explore ...

BMO Capital Markets managing director of biopharma equity research Evan Seigerman joins Market Domination to discuss the best ...

Those who graduate from the facility at Passaic County Technical Institute in Wayne will get associate’s degrees in ...

Legend Biotech's valuation is conservative, suggesting potential for significant appreciation and growth ahead. Click here to ...

Biotech Nuvalent unveiled updates on two experimental cancer medicines over the weekend. Analysts say each could be the best ...

Fortress Biotech shares are trading lower by 20% Friday afternoon. The company announced the pricing of a $8 million ...

EQS-News: BRAIN Biotech AG / Key word (s): Contract BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator 20.09.2024 / 19:50 CET/CEST ...

GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...